Comparison of Beta-adrenoceptor Coupled Camp Production in Cultured Human Mononuclear Leukocytes and Myometrial Cells by Liu, Yu-li
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
December 1997
Comparison of Beta-adrenoceptor Coupled Camp
Production in Cultured Human Mononuclear
Leukocytes and Myometrial Cells
Yu-li Liu
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Cell Biology Commons, Obstetrics and Gynecology Commons, and the
Pharmacology Commons
This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Liu, Yu-li, "Comparison of Beta-adrenoceptor Coupled Camp Production in Cultured Human Mononuclear Leukocytes and
Myometrial Cells" (1997). Electronic Theses and Dissertations. Paper 2940. https://dc.etsu.edu/etd/2940
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may be 
from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in reduced 
form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6” x 9” black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly to 
order.
UMI
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor MI 48106-1346 USA 
313/761-4700 800/521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
COMPARISON OF B-ADRENOCEPTOR COUPLED cAMP PRODUCTION IN 
CULTURED HUMAN MONONUCLEAR LEUKOCYTES AND MYOMETRIAL
CELLS
A Dissertation 
Presented to the Faculty of 
the Department of Pharmacology 
James H. Quillen College of Medicine 
East Tennessee State University
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in Biomedical Science
by
Yu-Li Liu 
December 1997
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 9903241
UMI Microform 9903241 
Copyright 1998, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized 
copying under Title 17, United States Code.
UMI
300 North Zeeb Road 
Ann Arbor, MI 48103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPROVAL 
This is to certify that the Graduate Committee of 
YU-LI LIU 
met on the 
7 day of November, 1997.
The committee read and examined her thesis, supervised her defense of it in an oral 
examination, and decided to recommend that her study be submitted to the Graduate 
Council, in partial fulfillment of the requirements for the degree of Ph.D. in Biomedical 
Science.
Chair, Graduate Committee
Signed on behalf of 
the Graduate Council
Interim Dean, School of Graduate 
Studies
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
COMPARISON OF B-ADRENOCEPTOR COUPLED cAMP PRODUCTION IN 
CULTURED HUMAN MONONUCLEAR LEUKOCYTES AND MYOMETRIAL
CELLS
by
Yu-Li Liu
B2-Adrenoceptor (B2-AR) agonists, such as terbutaline, are used as tocolytic agents in the 
treatment of preterm labor. B-Adrenoceptor stimulation relaxes myometrium through 
specific receptors coupled through Gs to adenylyl cyclase (AC) that catalyzes the 
conversion of ATP to cAMP.
The purpose of this study was to compare B-adrenoceptors and cAMP production in 
cultured human leukocytes and myometrial cells, and to determine the importance of B- 
adrenoceptors and cAMP production in isoproterenol-induced myometrial relaxation. 125I- 
iodopindolol was used to assess B-adrenoceptor affinity and number. cAMP levels were 
analyzed before and after stimulation by isoproterenol, A1F4‘, forskolin, and PGEt. 
Isometric recording was used to examine myometrium contraction and relaxation.
B-adrenoceptors in leukocytes and myometrial cells have similar 125I-iodopindolol binding 
affinity and B ,^ .  Both tissues can be stimulated by isoproterenol, but have reserve 
adenylyl cyclase activity not stimulated by B-ARs.
Cultured human myometrial cells have higher basal AC activity and lower isoproterenol 
coupled cAMP production than leukocytes. The rank order of B-adrenoceptor agonist 
potencies in leukocytes is: isoproterenol > terbutaline > ritodrine. Myometrial cells could 
not be stimulated by terbutaline or ritodrine. This indicates that the intrinsic activity of B- 
adrenoceptor coupled cAMP production is different in these two tissues.
Prolonged exposure to 200 nM terbutaline results in a decrease in both B-adrenoceptor 
number and isoproterenol-coupled cAMP production in cultured leukocytes and 
myometrial cells. Signal transduction factors, such as adenylyl cyclase and the PGE! 
pathway, are not affected by the down-regulation process.
Isoproterenol relaxes term myometrium through B2-ARs without a change in cAMP 
production.
Cultured leukocytes do not completely reflect the activity of B-adrenoceptor coupled
iii
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cAMP production to myometrial cultured cells. In myometrium, the presence o f B-ARs 
does not guarantee stimulation of cAMP production, and cAMP is not an accurate index 
of myometrial relaxation at the end of pregnancy. While leukocytes may accurately reflect 
changes in myometrial B-adrenoceptors, postreceptor differences suggest that they are not 
a reasonable indicator of myometrial response to B-AR stimulation.
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CHAPTER 1
INTRODUCTION
Uterine Contraction and B-Adrenoceptor Agonist Induced Relaxation 
Myometrial contractions occur through two major excitation-contraction coupling 
pathways: electromechanical coupling and pharmacomechanical coupling (Wray 1993). 
Electromechanical coupling decreases the membrane permeability to potassium and 
increases the membrane permeability to sodium. These permeability changes cause a slow 
depolarization which precedes an action potential (Parkington and Coleman 1990). The 
upstroke of the action potential is due predominantly to calcium entry, and the 
repolarization is due to K+ efflux and inactivation of the calcium channels (Parkington and 
Coleman 1988). Pharmacomechanical coupling releases intracellular Ca2+ and modulates 
the Ca2* sensitivity of the contractile regulatory apparatus through receptors (Somlyo AP 
and Somlyo AV 1994). Increased intracellular Ca2+ concentration results in the formation 
of an active complex between calcium, calmodulin (CaM), and myosin light-chain kinase 
(MLCK) (Barany K and Barany M 1990). Activated MLCK phosphorylates Seri 9 of the 
20 kDa myosin light chain, increasing actin-activated myosin Mg2+-ATPase activity (Allen 
and Walsh 1994). Myosin heads attach to actin, bind and hydrolyze ATP, reattach and 
undergo transition to a force generating state, release the hydrolysis product (ADP and PJ 
and again bind ATP, and repeat the contraction cross-bridge cycle (Somlyo and others 
1988).
Although intracellular Ca2+ concentration is the primary regulator for the 
contractile state of myometrium smooth muscle, smooth muscle contraction can also be
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2regulated by changing calcium sensitivity, and through a calcium-independent pathway. In 
rabbit portal vein permeablized with Staphylococcus aureus a-toxin, oq-adrenergic agonist 
phenylephrine produced an increase in force generation when the intracellular Ca2+ 
concentration was sufficient for partial contraction (Gong and others 1997). This 
pharmacomechanical coupling increases the calcium sensitivity o f the contractile 
regulatory apparatus, such as monomeric G protein (rhoA) translocation, and inhibition of 
myosin light chain phosphatase unmasks basal MLCK activity (Gong and others 1992). 
Decreased Ca2+ sensitivity of the contractile regulatory apparatus can occur if the muscle 
cells are exposed to high intracellular calcium concentration. This most likely occurs 
through activation of calmodulin kinase II (CaMK II) which catalyses phosphorylation of 
MLCK at Ser815, increasing its calcium requirement for force generation (Tansey and 
others 1992). Protein kinase C activator phorbol ester induced contractions in 
permeabilized vascular smooth muscle cells from ferret aorta when calcium was -1 nM 
(Walsh and others 1996). This calcium independent contraction involves the activation of 
e-isozyme of protein kinase C (PKC).
There are two physiological archetypes of myometrial smooth muscle contraction: 
tonic and phasic. Pure tonic contractions respond to excitatory agonists with an active 
tension and remain at that tension without visible rhythmic fluctuations in the mechanical 
recording. Pure phasic contractions consist of an initial transient peak, followed by a 
decline to a basal level (Somlyo AP and Somlyo AV 1994). These two types of 
contraction are usually mixed in myometrium.
Oxytocin induced phasic or tonic myometrial contractions at the end of pregnancy
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3occur through two pathways. One is through calcium influx by stimulation of a voltage- 
dependent and/or receptor operated calcium channel (Kawarabayashi and others 1997). 
The increased intracellular calcium concentration can further induce phospholipase C 
activation (Khac and others 1992). The other pathway is through the agonist-induced 
receptor-Gi protein-phospholipase C cascade activation (Meldrum and others 1991; 
Strakova and Soloff 1997). Phospholipase C catalyzes the hydrolysis of phosphatidyl 
inositol 4,5-bisphosphate to inositol trisphosphate (IPj) and diacylglycerol. Both products 
have intracellular second messenger function. Diacylglycerol stimulates protein kinase C, 
whereas EP3 causes a release of Ca2+ from intracellular stores. The contractile effects of 
oxytocin can be inhibited by nifedipine or ruthenium red, an inhibitor of Ca2+-induced 
calcium release (Phillippe and Basa 1996, 1997).
Myometrial contraction can be potently inhibited by B-AR agonist isoproterenol.
Its mechanism of action is mainly through increasing intracellular cAMP which activates 
cAMP-dependent protein kinase (A kinase) and phosphorylates myosin light chain kinase 
(MLCK), resulting in inhibition of MLCK from activation by Ca2+-calmodulin (Torphy
1994). Other than this central pathway, Khac and others (1996) found an alternate 
isoproterenol relaxant pathway in pregnant rat myometrium that is linked via a cAMP- 
independent, pertussis toxin-sensitive process to activation of K* channels. The activated 
K+ channels hyperpolarize the membrane, inhibit voltage-operated Ca2+ channels and 
induce a decrease in calmodulin activation (Biilbring and Tomita 1969; Kroeger and 
Marshall 1973, 1975). Ishine and others (1993) reported another pathway by examining an 
isoproterenol-induced relaxation of Wistar rat uterus in Ca2+-free solution. They conclude
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 1. KC1- and oxytocin-initiated myometrial contraction and fl-adrenoceptor-induced 
relaxation mechanisms.
that isoproterenol inhibits Ca2+-free myometrial contraction through a Br AR mediated 
cAMP pathway and K+ stabilization, and through a pathway which could not be blocked 
by phentolamine, timolol, or butoxamine.
B-Adrenoceptor Subtvpes and Uterine Relaxation 
B-AR subtypes may contribute differently to myometrial relaxation at the end of 
pregnancy. Since isoproterenol stimulates adenylyl cyclase through both Br  and B2-AR 
subtypes via an intermediate G protein (Gs), binding of either receptor subtype may 
activate adenylyl cyclase resulting in uterine relaxation (Wray 1993). Several studies 
indicate different expression of B-AR subtypes at the end of pregnancy. In pregnant rat 
myometrium, Maltier and others (1989) found the number of B2-AR decreases from 
gestation day 18 (433 fmole/mg protein) to day 21 (229 fmole/mg protein). The receptor 
number was constant between gestation days 21 and 22, but during the six hours before
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5parturition, decreased markedly (58.7 fmole/mg protein). B2-AR mRNA decreases linearly 
throughout the gestational period from day 0 to day 21 (Engstrom and others 1997). Five 
days after parturition, B2-AR mRNA increases 8 fold as compared to gestation day 21. 
However, Principe and others (1997) using quantitative reverse transcriptase-polymerase 
chain reaction technique observed a gradual decline in rat Br AR mRNA levels from day 
12 of gestation through postpartum day 1; in contrast, B2-AR mRNA levels remained 
stable, except for a variable nadir on the day of parturition (day 22). B2-AR selective 
agonist salbutamol is more potent in its inhibitory effect on rat spontaneous uterine 
contraction at the end of pregnancy than at the middle of pregnancy (Chemaeva 1984). 
There is no change during pregnancy in the inhibition of spontaneous uterine contractions 
by non-selective B-AR agonist isoproterenol (Chow and Marshall 1981). In human 
myometrium, Dattel and others (1986) found no change in B-ARs from women in labor or 
before labor between 28 and 34 weeks of gestation. They did not further analyze changes 
in receptor subtype. These results indicate the importance of examining human B, and B2- 
AR coupled myometrial response at the end of pregnancy.
Therapeutic Dosages and Limitations of B,-Agonists 
Preterm labor is defined by uterine contractions that develop between 20 and 37 
weeks gestation with progressive cervical dilation or effacement or both (Graf and Perez- 
Woods 1992). Preterm labor occurs in 7-8% of all births in the United States and accounts 
for a disproportionate percentage of perinatal, neonatal and infant morbidity and mortality 
(Caritis and others 1988). The cause of preterm labor is unknown. The tocolytic B2-AR 
agonists terbutaline and ritodrine, are commonly used in patients experiencing preterm
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6labor because B2-AR agonists produce uterine relaxation with minimal direct cardiac Br  
AR side effects (Berg and others 1982). These tocolytics can delay delivery for 48 hours. 
However, B2-AR agonists are not without disadvantages. These agents are B2-selective, 
but at high concentrations stimulate Br ARs and induce tachycardia. Cardiovascular side 
effects limit the dose and effectiveness of B2-AR agonists as uterine relaxants (Doggrell
1995). Continuous exposure to tebutaline or ritodrine produces a loss of uterine relaxation 
at therapeutic concentrations (Ryden and others 1982; Caritis and others 1987). Use of 82- 
AR agonists since 1980 has not improved the rate of preterm delivery (Macones and 
others 1995).
Leukocytes as Receptor-cAMP Index of Less Accessible Uterine Tissue 
Although the functional response of leukocytes to B-AR stimulation has not been 
studied extensively, B-ARs may be involved in modulation of immune response. 
Isoproterenol can block the expression of interleukin-2 receptors on human T lymphocytes 
(Feldman and others 1987). Interleukin-2 receptor expression and stimulation promotes T 
lymphocyte blastogenesis, clonal expansion, and differentiation. Furthermore, stimulation 
by B-AR agonists may selectively regulate specific lymphocyte subsets (Landmann 1992). 
Acute sympathetic activation by adrenaline infusion causes a selective increase in 
circulating CD56+ or CD57* natural killer lymphocytes which are rich in B-ARs. This 
selective immunomodulatory effect is probably a consequence of an elevation in 
intracellular cAMP. Knudsen and others (1995) correlated isoproterenol-stimulated cAMP 
production with lymphocyte subset composition in mononuclear cells isolated from resting 
human subjects and found NK-cells (CD3\ CD56+) and T cytotoxic cells (CD8+) produced
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7greater amounts of cAMP than T helper cells (CD4*) and B-lymphocytes (CD 19*,
CD2(T).
Leukocyte B-ARs have been correlated to different tissues or diseases in order to 
create an index for B-ARs in less accessible tissues (Connolly and others 1992; Zoukos 
and others 1994). In human myometrium, Michel and others (1989) simultaneously 
determined the density of B-ARs in human myometrium and lymphocytes derived from 36 
women undergoing cesarean section. The density of both myometrial and lymphocyte B- 
ARs was about 65-70% lower in women treated with the B2-AR agonist hexoprenaline for 
preterm labor compared to untreated women. The isoproterenol-evoked increase in 
lymphocyte cAMP content (as an index for lymphocyte B-AR responsiveness) was 
diminished to a similar extent in hexoprenaline treated women. Michel and others (1989) 
found a significant positive correlation between myometrial and lymphocyte 
beta-adrenoceptor densities (r = 0.7303; n = 36; p less than 0.001), and suggested that 
determination of beta-adrenoceptor number in circulating lymphocytes may be a useful 
model to monitor myometrial beta-adrenoceptor changes during tocolytic therapy. Berg 
and others (1984) correlated cAMP production between myometrial tissue and leukocytes 
in 21 women delivered by Cesarean section for obstetrical reasons. After in vitro B-AR 
stimulation, cAMP production was closely correlated between the two tissues (r = 0.96). 
However, myometrium membrane preparations can include membranes from different cell 
types, such as blood cells, endothelial cells, and connective tissue and may not represent 
intact pure myometrial cells. The purpose of the current investigation was thus to compare 
B-ARs and cAMP production in cultured intact leukocytes and myometrial cells.
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8B-Adrenoceptors
Ahlquist (1948) distinguished B-ARs from a-ARs based on the relative potencies 
of five phenethylamines (norepinephrine, epinephrine, a-methylnorepinephrine, a- 
methylepinephrine, and isoproterenol). Responses for isoproterenol, such as relaxation of 
peripheral blood vessels, relaxation of the uterus, and stimulation of cardiac rate and force, 
were designated as B-adrenergic. Lands and others (1967a, 1967b) proposed the presence 
o f two B-AR subtypes, named 6,- and B2-ARs. This divides B-AR responses generated by 
the neuronally- released norepinephrine from hormonal circulating epinephrine. Currently, 
a third subtype o f B-AR, B3 is known to be functionally expressed in mammals (Strosberg 
1993).
B-ARs have been purified to homogeneity from mammalian tissues and determined 
to be a single polypeptide chain o f62,000-67,000 Da (Lefkowitz and others 1983;
Benovic and others 1984; Cubero and Malbon 1984). Hydrophobicity analysis of the 
primary amino acid sequence of the B-AR indicates a pattern of seven repeating 
hydrophobic clusters (Dixon and others 1987; Dohlman and others 1987b; Lefkowitz and 
Caron 1988). The highest degree of amino acid homologies are retained in the 
hydrophobic sequences, while diversity is observed in the sequences of the N- and C- 
termini. In the extracellular loops, specific cysteines are conserved (Dohlman and others 
1987b; Malbon and others 1987), which may form disulfide bridges. In the hydrophobic 
helices, proline and glycine residues are retained (Strader and others 1987; Dixon and 
others 1988). These residues could be expected to cause kinks or bends in the helical 
structure. Potential N-linked glycosylation sites are present in the amino-terminal
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9segments of these receptors (Dohlman and others 1987a). Dohlman and others (1987a) 
and Wong and others (1988) using structurally distinct and selective B-AR photoaffinity 
probes demonstrated covalent labeling only in the hydrophobic transmembrane regions. 
Extensive treatment with protease had little effect on either agonist or antagonist binding 
to B-AR (Dohlman and others 1987a; Rubenstein and others 1987). Hydrophilic sequences 
appear to be less important for the integrity of functional coupling; thus, deletion of these 
segments had very little effect on ligand-binding. Together, these findings indicate that the 
ligand-binding site o f the B-AR exists within the hydrophobic core composed of the seven 
transmembrane-spanning elements.
Human mononuclear leukocyte B-AR were first studied using radioligand binding 
o f B-AR antagonist 3H-alprenolol by Williams and others (1976). Using homogenized cell 
membranes, they found a receptor density of 75 ± 12 fmol/mg protein, corresponding to 
about 2,000 sites/cell. The B-AR density evaluated by binding study may vary due to many 
reasons. Hydrophilic radioactive ligands might only measure the cell surface B-ARs. 
Motulsky and others (1986) found acute exposure to isoproterenol internalized the cell 
surface B-ARs and decreased the binding of hydrophilic B-AR antagonist [3H]CGP-12177 
in intact leukocytes. Use of tritiated ligands also has the disadvantage of low specific 
radioactivities and thus a large number o f cells may be required. Hydrophobic ligands l25I- 
cyanopindolol or 125I-iodopindolol are also used to assess intracellular and extracellular 
receptors (Thede-Reynolds and others 1986; von Mandach and others 1993). B-AR 
binding can also be influenced by preparation of cells or membranes, incubation 
temperatures, and other binding conditions. Additionally, Landmann (1992) suggested
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differences in B-AR number between leukocyte subpopulations. These conditions should 
be considered when comparing the results between different tissues or studies.
Hayashida and others (1982) found that beta-adrenergic antagonist [3H] 
dihydroalprenolol (DHA) binds to particulate preparations of human myometrium with a 
Kd of 0.50 nM and a of 70 fmoles/mg of protein. In human myometrium, the number
of ctj- and Bj-adrenergic receptors increase concomitantly with circulating plasma estradiol 
levels (Bottari and others 1985). This effect is counteracted by progesterone. Engelhardt 
and others (1997) compared 14 pregnant patients who had received B-AR agonist 
fenoterol and 14 untreated pregnant controls and found a decrease in B-ARs, but not in 
mRNA, Gs, Gi, or B-AR kinase activity following B-AR agonist fenoterol treatment.
The development of radioligand-binding techniques and adenylyl cyclase assays 
have greatly facilitated the subclassification of the B-ARs and the assessment of the tissue 
distribution of the Br , B2-, and B3-AR subtypes. In receptor binding studies, Br  and B2- 
ARs have shown a wide distribution and a colocalization in almost all tissues (Hieble and 
Ruffolo 1991). The B3-AR is found in both white and brown adipocytes in human, and 
mediates norepinephrine-induced lipolysis (Strosberg 1995). Whether the B3-AR is 
involved in other physiological roles remains a point for future investigation. No B3-AR 
have yet been reported in brain, leukocytes or uterus.
The colocalized subtypes of B-ARs are often characterized using displacement of 
radioligand binding by an unlabelled compound (Brodde and others 1983; Breuiller and 
others 1987; Beer and others 1988). If the compound has a selective binding affinity (KD) 
for each receptor subtype, the heterogeneous population of receptor subtypes will be
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measured. Highly selective antagonists have been used to analyze the colocalization of 
receptor subtypes. At the 6 , and B2-AR, CGP-20712A and ICI-118551 are potent 
antagonists, with KD values below 1 nM and subtype selectivity of greater than 100 fold 
(Bilski and others 1983; Lemoine and others 1985; Molenaar and Summers 1987). 
Analyzing the displacement o f radioligand by Br  or B2-AR antagonists can provide an 
estimation of the percentage o f Br  and B2-sites in a particular tissue preparation (Hieble 
and Ruffolo 1991).
Agonist and antagonist selectivities at the binding domains of B-ARs have been 
evaluated in different receptor subtypes. Frielle and others (1988) synthesized a number of 
chimeric DNAs which were constructed by substituting various domains of the seven 
transmembrane Bj-AR for their counterparts in the B2-AR. The chimeric B^B^ARs were 
expressed in Xenopus laevis oocytes and assayed for agonist- and antagonist- radioligand 
displacement. The results suggest that subtype specificity is determined by most of the 
transmembrane regions of the molecules. This supports the idea that binding of ligands by 
B-ARs occurs in a pocket formed by the membrane-spanning a-helices.
G Proteins
G proteins are heterotrimers composed of a, B, and y subunits. The a-subunit 
defines an individual G protein oligomer. The B- and y-subunits exist as a tightly 
associated complex that functions as a unit. The same By subunit complex can be shared 
among different a-subunits to form the heterotrimer. The a-subunits have a single high 
affinity binding site for guanine nucleotides (GDP or GTP). The GDP-bound form of a 
binds tightly to By and is inactive; on the other hand, the GTP-bound form of a  dissociates
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from By and serves as a regulator of effector enzymes. Aluminum tetrafluoride (A1F4*), 
together with Mg2*, interacts with GDP to mimic GTP and, thereby, activates Ga (Hepler 
and Gilman 1992). The G protein a-subunit can further be divided into four major 
subfamilies: Gs, Gi, Gq, and G12. Receptors like B-AR interacting with the Gs family 
stimulate AC; receptors such as c^-AR interact with the Gi family and inhibit AC; and 
receptors such as a,-AR interact with the Gq family and activate phospholipase C-B (PLC- 
B) (Hepler and Gilman 1992). Although the effector for the G12 family has not been well 
defined, Na+-H* exchanger is regulated by G12 (Lin and others 1996).
G proteins are widely distributed in all tissues (Kaptein and others 1995). In human 
mononuclear leukocytes, including lymphocytes and macrophages, G proteins are coupled 
not only to B-ARs, but also to other similar seven-transmembrane receptors, such as those 
for chemoattractants C5l, platelet-activating factor, and interleukin 8 (IL-8) (Gerard C and 
Gerard NP 1994; Murphy 1994). This suggests the involvement of G proteins in the 
regulation of acute and chronic inflammation (Murphy 1994).
In myometrium, Cohen-Tannoudji and others (1995) using immunoblot and 
hybridization blot analysis found that estradiol had significantly increased the levels of both 
Gi2a subunit and Gi2a mRNA at the end of pregnancy. Gqa protein and mRNA were 
also significantly lower at midpregnancy under progesterone dominance compared with 
term. These results demonstrate that myometrial Gi2a and Gqa subunits are physiological 
targets for estradiol and progesterone, respectively, in vivo. Alterations of these G protein 
levels are related to their mediating effects on adenylyl cyclase activity or the 
phospholipase C pathway during the course of pregnancy. Lopez-Bemal and others
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(1995) suggested that pregnancy is associated with changes in G-protein signaling and 
second messenger formation in human myometrium. During gestation, uterine relaxation is 
favored by a pronounced increase in cAMP formation. The change in Gas is reversed in 
spontaneous labor, enabling the uterus to become responsive to contractile agents.
Adenvlvl Cvclase
The enzyme adenylyl cyclase (AC) functions as an effector molecule that transfers 
the signal of activated B-AR through Gas to a cellular response. This enzyme catalyzes the 
formation of cyclic 3',5-adenosine monophosphate (cAMP) from ATP. Cloning studies 
have identified at least eight different types of AC (Krupinski and others 1989; Mons and 
Cooper 1995). All known AC species can be directly stimulated by forskolin, a diterpene 
isolated from the roots of the aromatic herb Coleus forskohlii (Seamon and Daly 1981). 
This has greatly aided the isolation and purification of AC from the heart and brain by 
means of affinity chromatographic techniques (Coussen and others 1985; Pfeuffer and 
others 1985; Yeager and others 1985; Smigel 1986).
AC consists of a single glycoprotein chain with a molecular weight of -150,000 Da 
(Pfeuffer and others 1985; Smigel 1986). It encodes the topology of tandem repetition of 
a hydrophobic putative transmembrane domain that spans the membrane six times and a 
large hydrophilic cytoplasmic domain (Gao and Gilman 1991). Based on amino acid 
sequence similarities, the subtypes of AC have been classified into three subfamilies: the 
type I-like group (subtypes I, HI, and VIII); the type 0-like group (subtypes O, IV, and 
VO); and the type V-like group (subtypes V and VI) (Tang and Gilman 1992; Iyengar 
1993; Cali and others 1994; Taussig and Gilman 1995). These subfamilies share certain
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functional properties, although each individual subtype displays a unique response to 
different stimuli (Bourne and Nicoll 1993; Anholt 1994; Cooper and others 1995; Taussig 
and Gilman 1995). Each AC can be regulated by a subunits of a G protein (Tang and 
Gilman 1992; Iyengar 1993), except the type I-like group which is refractory to 
stimulation by Gas (Tang and others 1991), and the type II-like group which is refractory 
to inhibition by Gai (Taussig and others 1994). These diverse modes of regulation result 
in more regulatory options in tissues containing AC. The subtypes of AC in leukocytes 
have not been defined. In myometrium, Kumasaka and others (1996) used reverse 
transcriptase and polymerase chain reaction methods to identify the appropriate molecular 
weights for AC subtypes HI, IV, V, VI, and VTII from rat myometrium. This suggests that 
complex interactions with multiple signal transduction pathways might exist in uterine 
smooth muscle.
Desensitization and Down-Reeulation of 0-Adrenoceptors 
Continuous exposure of B-ARs to an agonist often leads to an attenuation of signal 
transduction. This agonist-induced process is called desensitization, refractoriness, or 
tolerance (Nijkamp and others 1992). Desensitization can be broken down into rapid and 
delayed processes (Stiles and others 1984; Dohlman 1991). Rapid desensitization is 
characterized by the attenuation of signaling within seconds to minutes of exposure to the 
agonist, and a rapid recovery even in the absence of protein synthesis (Dohlman 1991). 
There are two major patterns of rapid desensitization, referred to as homologous and 
heterologous desensitization (Lefkowitz and others 1980).
Homologous desensitization is a phenomenon which is receptor specific, such as
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that affecting only B-ARs (Lohse and others 1990). Homologous desensitization of B-ARs 
is a multistep process associated with uncoupling of receptors from G-protein and 
phosphorylation by B-AR kinase, which translocates from cytosol to membrane during B- 
AR stimulation (Strasser and others 1986). B-Arrestin is required to effect the 
homologous desensitization triggered by agonist occupancy and B-AR kinase 
phosphorylation of the receptor (Collins and others 1991). Another is a sequestration of 
the receptor away from the plasma membrane. Sequestration acts as a mechanism for the 
dephosphorylation of the receptor, which allows subsequent resensitization (Sibley and 
others 1986).
Heterologous desensitization is a process whereby activation of one type of 
receptor causes the desensitization o f other types of receptors as well (Lohse and others 
1990). Heterologous desensitization does not usually involve receptor sequestration and 
appears to be mediated by cAMP. Therefore, prostaglandin E,, which stimulates 
prostaglandin receptors and increases the cAMP level, can be used as a measure of 
heterologous desensitization occurring after B-AR stimulation. Nevertheless, heterologous 
desensitization shares a similar pathway as homologous desensitization in receptor 
phosphorylation and impairment of AC activation (Dohlman 1991; Nijkamp and others 
1992).
Delayed desensitization or down-regulation is characterized by a decrease in the 
total number of B-AR with an accompanying loss in effector stimulation over hours to 
days of agonist treatment, and the requirement for de novo protein synthesis for recovery 
o f receptor number (Hausdorff and others 1990; Dohlman 1991; Von Zastrow and
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Kobilka 1992). Two pathways have been hypothesized for down-regulation. One is an 
acceleration of receptor degradation, presumably in lysosomal vesicles. Another is the 
decrease in receptor biosynthesis (Morishima and others 1980; Doss and others 1981; 
Wakshull and others 1985). The first pathway was studied by Von Zastrow and Kobilka 
(1992). They found the cellular pathway and compartments that mediated the 
internalization o f ARs through a endosome recycling process. As diagrammed in Fig. 2, 
receptor internalization (arrow A) can occur at a substantial rate without intracellular 
accumulation of receptors, pro viding that the recycling rate (arrow B) is comparably 
rapid. Nevertheless, this receptor internalization and recycling traffic can be sufficient to 
supply a degradative pathway from endosome to lysosome (arrow C). This contributes to 
the down-regulation of receptors in the absence of marked sequestration. By manipulating 
the relative rates of the individual steps (represented by the arrows), the cell could 
independently regulate receptor sequestration (accumulation in endosomes at steady state) 
and down regulation (sorting of a portion of receptors passing through endosomes to 
lysosomes). Prolonged exposure to either B-AR agonists or cAMP analogs produced a 
loss o f receptor binding sites, accompanied by substantial decreases in B2-AR mRNA 
levels (Hadcock and Malbon 1988; Collins and others 1989).
Statement of the Problem 
The presence o f B-ARs in human mononuclear leukocytes and myometrial cells has 
been established (Williams and others 1976; Motulsky and Insel 1982). It is conceivable 
that the function or interaction between B-ARs, Gas, and AC may play an important role 
in regulating the signal transduction process (Nijkamp and others 1992). B-ARs in
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Endosome Sorting
Lysosome
Degradation
Figure 2. Proposed model of cellular pathways mediating sequestration 
and down-regulation of B-ARs.
circulating mononuclear leukocytes have been used as an index for assessing B-AR 
function in less accessible tissues in humans (Motulsky and Insel 1982; Brodde and others 
1987). Berg and others (1984) and Michel and others (1989) compared B-AR density and 
cAMP production in human leukocytes and membrane preparations of human 
myometrium and suggested that the tissues reflea one another. In order to explore the 
similarity between human myometrium and leukocytes, the hypothesis is established that 
similar B-AR and coupled cAMP produaion is present in cultured human mononuclear 
leukocytes and myometrial cells.
Since B, and B2-ARs coexist in human myometrium and both receptor subtypes 
couple Gs protein and stimulate adenylyl cyclase, it is possible for both receptor subtypes 
to contribute to isoproterenol-induced relaxation during pregnancy. Results from rat
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uterus have generated controversies concerning receptor subtypes at the end of pregnancy, 
Maltier and others (1989) and Engstrom and others (1997) found a decrease in both B2- 
AR protein and mRNA levels, while Principe and others (1997) found a decreased at 
mRNA for Bt-AR but not B2-AR. B2-AR selective agonist potently inhibits rat uterine 
contraction which suggests a predominant function of B2-AR at the end of pregnancy 
(Chemaeva and others 1984). In human, the contribution of Br  AR in relaxation of uterine 
tissue has not been investigated. Therefore, the second hypothesis is established that there 
is a proportional contribution from Br  and B2-ARs in the isoproterenol-induced human 
myometrial relaxation at the end of pregnancy.
Aim of the Study
This study compares B-ARs and cAMP production in human mononuclear 
leukocytes and cultured myometrial cells, and examines the receptor subtypes involved in 
isoproterenol-induced myometrial relaxation. Experiments were designed to assess the 
effect of terbutaline treatment on receptors and cAMP production, and isoproterenol- 
induced myometrial relaxation. The experimental goals of the study include:
1. To establish experimental conditions for the isolation and culture of human leukocytes 
and myometrial cells, and measurement of B-AR binding, cAMP production and 
myometrial relaxation.
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2. To compare B-AR properties and cAMP production between cultured leukocytes and 
cultured myometrial cells, and assess alterations produced by exposure to B2-AR agonist 
terbutaline.
3. To determine the contribution of Br  and B2-AR subtypes in isoproterenol-induced 
myometrial relaxation.
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CHAPTER 2
MATERIALS AND METHODS
Protocols using tissue from consenting adults were approved by the Institutional 
Review Boards of East Tennessee State University and the Johnson City Medical Center. 
All reagents were purchased from Fisher (Pittsburgh, PA) unless otherwise noted.
Relaxation Study of Human Myometrium
Preparation of Uterine strips
Uterine tissue was collected at the Johnson City Medical Center from HIV- 
seronegative women (age 19 to 39 years) requiring cesarean delivery at 39-40 gestational 
weeks. Isolated uterine muscle strips were prepared using a modification of the method of 
Word and others (1992). Myometrial biopsies obtained from women requiring caesarean 
section were transported in oxygenated physiological salt solution (NaCl, 120.5 mM; KC1, 
4.8 mM; CaCl2-2H20 , 1.6 mM; MgCl2 -6H20, 1.2 mM; NaHC03, 20.4 mM; NaH2P04 - 
H20 , 1.2 mM; Dextrose, 10 mM; pyruvate, 1 mM, pH 7.4), maintained at room 
temperature. Tissues were immediately dissected into strips longitudinal to the muscle 
fibers with a dimension approximately 1 x 0.2 x 0.2 cm and were mounted in 12 ml organ 
baths containing physiological salt solution (PSS) at 37°C. One end of each strip was 
attached to a fixed hook, the other end to an FT03C isometric force displacement 
transducer (Grass Model 7D polygraph, Quincy, MA). After mounting, a recovery period 
of 2 hrs was allowed until a stable baseline has achieved. The buffer in the organ baths was
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replaced with prewarmed PSS solution at least every 30 min, and continuously aerated 
with a mixture of 95% 0 2 and 5% C 02.
Leneth-Tension and Relaxation Response
The myometrium muscle strip was maintained at a resting tension o f 1000 mg. 
Optimal resting tension was determined by contracting tissues with 65 mM KC1 and 
adjusting resting tension to achieve maximal contraction. A KC1 concentration of 35 mM 
was chosen for producing sustained contraction and greatest isoproterenol relaxation. 
Subsequently, cumulative concentrations of isoproterenol were added to relax the strips in 
the presence of 35 mM KC1. Washout and re-equilibration (minimum 80 min) separated 
sequential exposure to isoproterenol in the absence and presence of 0.1 pM ICI-118551 
((±)-1 -[2,3-dihydro-7-methyl- lH-inden-4-yl)oxy]-3-[( 1 -methylethyl)amino]-2-butanol 
hydrochloride, Research Biochemicals International, Natick, MA), or 0 .1 pM CGP- 
20712A ((±)-2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[ 1 -methyl-4-(trifluoromethyl)- 1H- 
imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate, Research 
Biochemicals International, Natick, MA). Tissues were pre-exposed to selective B-AR 
antagonists for at least 80 min. The detail experimental design is shown in Fig. 3.
Quantification of Contractile and Relaxation Response
Responses to individual isoproterenol concentrations were measured as the 
maximum relaxation occurring 5 to 10 min after exposure. Comparisons of relaxation 
between tissues tested with isoproterenol, isoproterenol in the presence of ICI-118551 or 
isoproterenol in the presence of CGP-20712A were made by normalizing tissue responses
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KG 35 mM W ash 5 times
Tissues into Organ Bath 2nd hr In 80 min KG 35 mM
1st hr 10 min after KG 35 mM AddlCI 10 min after KG 35 mM
KG 65mM Start Isoproterenol or CGP Start Isoproterenol
for 1 min & wash from 10s  to Iff5 M from Iff8 to Iff3 M
O rgan Bath 1: Control: Isoproterenol + Isoproterenol
O rgan Bath 2: ICI-118551: Isoproterenol + IG
O rgan Bath 3: CGP-20712A: Isoproterenol + CGP
Figure 3. Experimental design for isoproterenol-induced relaxation.
between the KCl-induced contraction at 10 min (100%) and resting tension (0%). The 
average tissue weight was 46.9 ± 2.3 mg (n=8). The cross-sectional area (square 
centimeters) of each tissue was determined by the following formula: W/(LxD), where W 
is the wet weight of tissue in grams, L is the stretched length in centimeters, and D is 
tissue density (1.05 g/cm3). The average cross-section was 0.031± 0.002 cm2 (n=8), the 
average stretched tissue length was 1.45 ± 0.035 cm (n=8), and the average tissue width 
was 1.75 ± 0.041 mm (n=8). The percentage relaxation at varying concentrations of 
isoproterenol was resolved by nonlinear least-squares curve fitting to the following 
equation using GraphPad Prism (San Diego, CA) to give the minimum and maximum 
relaxation as well as the ECjo value for each experiment.
n , .... . ..  . Maximum-MinimumRelaxations/a) = Minimum *
1 +  io 00®^50 "  h*VmProUrm,cb
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The pKB of ICI-118551 was calculated for individual tissues from the dose ratio (dr) of 
isoproterenol concentrations producing 15% relaxation in the presence and absence of 
ICI-118551 using the following relationship:
pK a = log(dr-l) - log[/C/-118551]
Human Mononuclear Leukocytes Isolation and Culture
Mononuclear leukocytes were isolated by a modification of the method of Boyum
(1968), but were maintained at 4°C during isolation to inhibit alterations in leukocyte (5-
*
adrenoceptors. Heparinized whole blood (143 units/ 10 ml) was removed by venipuncture 
from healthy male volunteers (age 25 to 42 years). Blood from female volunteers was used 
only for preliminary experiments. Blood was diluted with an equal volume of DPBS 
containing 10 mM Ca2\  10 mM Mg2* (Sigma, St. Louis, MO) and layered onto 
Histopaque-1077 (Sigma). After separation by centrifugation at 400xg for 40 min, the 
layer containing mononuclear leukocytes was removed and washed three times with DPBS 
by pelleting at 400g for 10 min. The freshly isolated cells were counted in a 
hemocytometer.
Cell viability was evaluated by trypan blue exclusion. A sample of each cell 
suspension was mixed with an equal volume of 0.4% trypan blue in DPBS solution. The 
mixed cell suspension was transferred to the edge of the coverslip and was allowed to run 
into the counting chamber of the hemocytometer. The total number of cells and the stained 
cells were counted separately. Cells excluding dye were considered viable. The percentage 
o f living cells was greater than 90% when assessed by this method.
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Freshly isolated leukocytes were resuspended in DPBS for assay of B-ARs and 
cAMP production or were incubated in a 25 cm2 stand-up flask at 37°C with 95% air- 5% 
C 02 for three days in RPMI-1640 medium containing 20% FCS (HyClone, Logan, UT) 
and 1% antibiotic antimycotic solution (Sigma). After three days of incubation, the 
leukocytes were centrifuged at 400xg for 10 min and washed twice with DPBS buffer.
The incubated cells were resuspended in the same DPBS buffer for further assay.
Human Myometrial Isolation and Cell Culture 
Uterine samples were obtained from the upper transverse incision at the lower 
anterior uterine wall (outer layer) and were cultured using a slight modification of the 
method of Casey and others (1984). Immediately after surgery, a small specimen of 
myometrium was placed in ice-cold DPBS containing 10% antibiotic antimycotic solution.
Myometrium was washed and cut to ~ 1 mm3 pieces in DPBS containing 10% 
antibiotic antimycotic solution and transferred to DPBS containing 2% antibiotics and 
0.25 mg/m1 collagenase Type II (from Clostridium histolyticum\ Worthington 
Biomedicals, Freehold, NJ). The preparation was disaggregated by agitating for 16 hrs at 
37° C in an incubation bath and filtered through four layers of gauze to remove 
nondispersed tissue fragments. The filtrate was centrifuged at 600xg for 10 min at 4°C 
and washed with culture medium DMEM-F12 containing 10% FCS. The cells were grown 
in T7J flasks to confluence in a 95% air-5% C02 incubator at 37°C with biweekly medium 
changes. Confluent cells were detached by treatment with 5 ml of 0.1% trypsin, 0.25% 
EDTA in Ca2+, Mg2+-free DPBS at 37°C incubator for 5 min. After the cells were
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
25
detached, 5 ml of 10% FCS containing DMEM-F12 medium was added to neutralize the 
trypsin. The cell suspension was centrifuged at 600xg for 10 min, washed twice by DPBS 
buffer and resuspended in the same buffer for further assay. Cell number and viability were 
analyzed by hemocytometer and trypan blue exclusion. Cultured myometrial cells were 
used within seven passages.
Myometrial Smooth Muscle Cell Identification 
Myometrial cells were identified using a fluorescent specific filamentous actin- 
binding toxin, 7-diethylamino-3-(4-isothiocyanotophenyl)-4-methylcoumarin (CPITC)- 
phalloidin (Sigma). Cells cultured in a two well chamber slide were fixed in DPBS 
containing 3.7% formalin, washed with DPBS and dried by air. Fixed cells were incubated 
with CPITC-phalloidin (final concentration 0.05 mg/ml in DPBS) for 20 min at room 
temperature, washed twice with DPBS, mounted in 30% glycerol and viewed with a 
fluorescent microscope using UV light and filter 475 BG3 (Olympus BH model).
Tissue. Disaggregated Cell, and Culture Cell Membrane Preparation 
Myometrial tissue, disaggregated cells or detached 24 hrs cultured cells were 
washed, minced on ice (tissue), suspended in 50 mM Tris-HCl (pH7.4) 0.25 M sucrose 
buffer, and homogenized using a Tissumizer (Tekmar; Cincinnati, OH) for 1 min at 
maximum speed. Tissue homogenates were filtered through three layers of gauze. 
Homogenates were centrifuged at 600xg for 10 min at 4°C. The supernatant was 
collected, the pellet was resuspended and homogenized in Tris-sucrose buffer and 
centrifuged at 600xg for 10 min at 4°C. The two supernatants were combined and
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centrifuged at 105,000xg (35,000 rpm) for 60 min at 4°C in a Beckman (Palo Alto, CA) 
model L5-65B preparative ultracentrifuge with a 50.2 Ti rotor. The final pellet containing 
the membrane fraction was suspended in 50 mM Tris-HCl (pH7.4). Protein concentration 
was measured by the method of Bradford (1976) and the volume adjusted to give 
appropriate protein concentration.
B-Adrenoceptor Saturation Binding Study 
Intact freshly isolated leukocytes, incubated leukocytes or myometrial cells were 
incubated at 37°C in a 96-well Multiscreen GF/C glass fiber plate. The assay volume (0.2 
ml) contained 4x10s leukocytes or 2x10s myometrial cells and 2.5 to 600 pM 
concentrations of radioligand [l2SI]-(-)-iodopindolol (from New England Nuclear, Boston, 
MA) in DPBS. Following equilibration for 30 min (leukocytes) or 60 min (myometrial 
cells), the mixture was filtered and washed three times with 0.25 ml of ice cold 25 mM 
MOPS (3-[N-morpholino]propanesulfonic acid) buffer (pH 7.4) using a Vaccu-pette/96™ 
(DBM Scientific, Valencia, CA). Filters containing radioligand were counted in a 
Beckman Gamma 7000 gamma counter.
Saturation Binding Data Analysis
The 12SI-iodopindolol - p-adrenoceptor dissociation constant (KD) and P- 
adrenoceptor density (B ,^ )  were estimated by weighted (Y*2) nonlinear least squares 
regression using GraphPAD Inplot (San Diego, CA). A model for one specific receptor 
binding site plus linear nonspecific binding (KNONSPEaFIC) was used:
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
27
B u .y  *  [ 251-IODOPINDOLOL]
Total Binding = ---------— ---------------------------------------  ♦ KNONSPEcmc *  [l25I-IODOPINDOLOL]
K d * [l25I-IODOPINDOLOL] m h s p e o f ic  i
Curve fitting resolved total binding into specific binding to B-adrenoceptors and 
nonspecific binding. The KD is the dissociation constant for 125I-iodopindolol, the Bmax is 
the maximum specific binding, and the KNONSPEaFIC is the nonspecific binding constant. 
After similar values appeared repeatedly at 33.3 pM, the program LIGAND (Biosoft, 
Cambridge, UK) was used to fix I25I-iodopindoloI KD in down-regulation experiments for 
estimation of B ^ ^  for individual patients (Munson and Rodbard 1980).
B-Adrenoceptor Displacement Binding Study 
Resuspended intact leukocytes and myometrial cells were incubated with a fixed 
concentration of 125I-iodopindoIol between 70-120 pM. The cell number, buffer and 
incubation time were the same as those for saturation binding. B-AR antagonist ICI- 
118551 was incubated at varying concentrations with each cell type. After incubation, the 
buffer was immediately vacuumed through GF/C glass fiber filters and washed three times 
with 0.25 ml of ice cold 25 mM MOPS buffer which was applied using a Vaccu- 
pette/96™ (DBM Scientific, Valencia, CA). The radioactive filters were punched out and 
the retained radioactivity measured by a Beckman Gamma 7000 counter.
The membrane preparation of myometrial tissue, disaggregated cells, or 24 hrs 
cultured cells used to measure total and B-AR receptor subtypes was modified from 
Nimmo and others (1995) and Breuiller and others (1987). Cell membranes from each 
group containing (final concentration) 50 pg protein were incubated for 1 hr on a
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Multiscreen GF/B filter plate with 35 pM of I23I-iodopindolol in 200 pi o f 50 mM Tris- 
HCl pH 7.4, 5 mM MgCl2, 154 mM N ad , 1 mM ascorbic acid, and 0 .1% bovine serum 
albumin at 37°C. Samples were filtered by vacuum, washed three times with 0.25 ml cold 
washing buffer (50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 154 mM NaCl, 1 mM ascorbic 
acid) and the retained radioactivity measured by a Beckman Gamma 7000 counter.
Non-specific binding was determined by incubating I23I-iodopindolol in the 
presence of 1 pM (-)-propranolol. ICI-118551 (0. 1 pM) or CGP-20712A (0.1 pM) were 
used to selectively block B2-ARs or B,-ARs respectively (Molenaar and Summers 1987; 
Molenaar and others 1988).
Displacement Binding Data Analysis
In intact cells. The K,, and are the dissociation constants of ICI-118551 at Br  
and B2-adrenoceptors respectively. The dissociation constants were derived from the IC^ 
values obtained from the following equation:
{Max -Bottom)*{fraction.) {Max -Bottom) * (1 -fraction.)
Binding = Bottom + ---------------------------------  +■-------------------------------------
[ i + i o ^ '00^
The binding was resolved by curve fitting into two specific displacement binding sites to 
B-adrenoceptors and nonspecific binding (Bottom). The “Max” is the maximum total 
binding in the absence of competing drugs, the “Bottom” is the nonspecific binding, 
“fraction," is the fraction of Br adrenoceptors, and the remaining specific binding “1- 
fraction," is the fraction of B2 adrenoceptors, the “F  is the Log of the antagonist 
concentration, and the IC50, or IC502 are the concentrations displacing 50% of binding to
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B,- or 02-adrenoceptors. The Kj! and are transformed from the respective IC50 using 
the Cheng and Prusoff (1973) relationship,
K = _______ IC50
' j t [1251 -Iodopindolol]
where KD is the dissociation constant of l25I-iodopindolol, and the [125I-iodopindolol] is the 
molar concentration o f the radioligand.
The following equation was used to calculate the F values for determining a one- 
site versus a two-site model for competition by ICI-118551:
SS, - SS2 
dFx -  dF2
F(dFrdF^j ^
W 2
SS, and SS2 are residual sums of squares with corresponding degrees of freedom 
dFt and dF2 for one- and two-site models, respectively. This value was calculated by 
GraphPAD Prism (San Diego, CA).
In membrane preparations. B-ARs are presented as finole/mg protein. Total B-ARs 
were obtained by subtracting binding in the presence of propranolol from total binding. B2- 
ARs were calculated as the mean of: a) the difference between binding displaced by ICI- 
118551 and total binding and b) the difference between binding displaced by propranolol 
and binding displaced by CGP-20712A. Bt-ARs were calculated as the mean of: a) the
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difference between binding displaced by CGP-20712A and total binding and b) the 
difference between binding displaced by propranolol and binding displaced by ICI-118551. 
Each value was doubled because the radioligand concentration 35 pM binds 50% of total 
B-AR. The number of total B-ARs and each receptor subtype in myometrium, 
disaggregated cells, and 24 hrs cultured cells were compared by ANOVA. Dunnet’s test 
was used for further multiple comparisons.
cAMP Production and Radioimmunoassay
In intact cells
cAMP production was measured using the method of Halper and others (1984) in 
the absence or presence of B2-adrenoceptor agonists (terbutaline or ritodrine), (-)- 
isoproterenol (1 pM), G protein stimulant A1F/ (10 mM NaF/10 pM A1C13), direct 
adenylyl cyclase activator forskolin (24 pM), or nonadrenergic adenylyl cyclase activator 
prostaglandin Et (PGE^ 10 pM). Additionally, the assay contained 106 leukocytes or 
5x10s myometrial cells and 20 or 200 pM of phosphodiesterase inhibitor 3-isobutyl-1- 
methylxanthine (IBMX) in a final volume of 1 mL. Following incubation at 37°C for 15 
min, the reaction was terminated by boiling for 5 min. The mixture was centrifuged at 
2500xg for 15 min at 4°C and the supernatant frozen at -80°C for later cAMP analysis.
In membrane preparations
AC was measured using a modification of the technique of Litime and others 
(1989). Cell membranes (20 pg protein) from each group were incubated without (basal)
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or with isoproterenol (1 pM), or forskolin (24 pM) in glass tubes containing final 
concentrations of 50mM Tris-HCl, 5 mM MgS04, 0.05 mM ATP, an ATP-regenerating 
system (5 mM creatine phosphate and 120U/ml creatine phosphokinase), 0.1% bovine 
serum albumin (fraction V) and 0.2 mM IB MX at 37°C for 10 min. The reaction was 
terminated by boiling for 5 min. The mixture was centrifuged at 2500xg for 30 min at 4°C 
and the supernatant frozen at -80 °C for later cAMP analysis. Forskolin-stimulated cAMP 
production was considered as an internal control for adenylyl cyclase activity.
The supernatant was assayed using a cAMP radioimmunoassay (RIA) kit. The 
standard cAMP solution was diluted to seven concentrations from 50 pmole/ml to 0.5 
pmole/ml. Including a total counts (cAMP [I25I]-tracer), a blank (cAMP [125I]-tracer with 
two volumes of assay buffer), and a zero standard (cAMP [125I]-tracer and equal volumes 
of cAMP carrier serum and assay buffer), these 10 standard tubes were assayed in 
duplicate. For each standard or sample tube, except the total counts tubes, 50 pi was 
pipetted into wells of a 96-well Multiscreen GF/C glass fiber plate. Diluted tracer (50 pi) 
solution, containing equal amounts of cAMP [l25I]-tracer and cAMP carrier serum, was 
added to each well. Diluted antiserum complex (50 pi) was added to each well and the 
plate was covered and incubated at 2-8 °C overnight (16-18 hours). The total counts tubes 
were set aside. Following incubation cAMP precipitator (125 pi) was added to each well. 
After mixing, the plate was vacuum filtered. The total counts tubes and the GF/C filters 
were counted in a Beckman gamma counter for two minutes per sample. The average of 
two blank counts was subtracted from the average standard or sample counts as an 
average net count. The net counts for each standard or sample were expressed as a
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percentage of the average net count for the zero standard. This is called "normalized" 
percent bound or %B/B0.
o/qB/b  _ Average Net Counts o f  Standards, Samples x jqq 
0 Average Net Counts o f  Zero Standard
The %B/B0 for each standard was plotted against the corresponding Log scale 
concentration of cAMP in pmole/ml. Each experimental sample was interpolated from the 
standard curve.
The value for cAMP production was corrected to give pmole per 106 cells per 15 
min for intact cells. The background cAMP level of the membrane preparation incubation 
buffer was subtracted. A linear relationship between membrane protein and cAMP 
production was obtained. cAMP production in membrane preparations is presented as 
pmole per mg protein per 10 min.
Long-term 200 nM Terbutaline Treatment for Cultured Leukocytes and Myometrial Cells
Myometrial cells or leukocytes were exposed to 200 nM terbutaline for 0 
(control), 1 or 3 days before the cells were used to assess B-ARs and cAMP production 
according to the design in Fig. 4.
Statistics
Values are summarized as mean ± standard error. The KD and B , ^  were analyzed 
by paired or unpaired t-test depending on experimental design. A three-way analysis of 
variance was used on cAMP data to assess leukocyte group (fresh or incubated), cAMP 
stimulation (basal, isoproterenol, A1F<‘, forskolin, or PGE,) and the interaction. Analysis
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Cell Culture Time Course
Control I
1 Day I
3 Day I 1
0 Day 1 Day 2 Day 3 Day Assay start
I I
A Add Terbutaline
J _____________ I
A  Add Terbutaline 
Figure 4. Experimental design for long-term 200 nM terbutaline treatment.
of variance was also used in comparing cAMP stimulation in myometrial cells and 
leukocytes, and in total B-AR, receptor subtypes, and cAMP production in fresh 
myometrium, disaggregated cells or 24 hrs cultured cells. Because of heterogeneous 
variances across the experimental conditions in Fig. 14, 21, 22, the student's paired t-test 
or unpaired t-test was used for comparison of means. Statistical analysis was performed 
using GraphPAD Prism and MINITAB (Addison-Wesley, Reading, PA) software. P 
values of less than 0.05 were considered significant.
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RESULTS
Cellular Isolation Conditions in Leukocytes and Myometrium
Effect of Ca2*. Mg2* on Leukocyte cAMP Production
When mononuclear leukocytes were washed in Ca2*, Mg^-free DPBS buffer, 
isoproterenol-coupled cAMP production was decreased by 74% from 14.9 ± 1.3 to 3.9 ± 
0.6 (Fig. 5). There was no apparent shift in the EC50 for isoproterenol between Ca2*, Mg2* 
containing buffer (16nM; pEC^ = 7.8 ± 0.1, n=5) and Ca2+, Mg2* free buffer (20nM; 
pECso = 7.7 ± 0.1, n=4).
-♦•With Ca2+, Mg2+
O  Without Ca2+, Mg2+
c
o
• I
o
3
T3
O
S
<
o
B -10 -9 -8 -7 -6 -5 -4 -3
Log[lsoproterenol], M
Figure 5. Basal (B) and isoproterenol-stimulated cAMP production in freshly 
isolated leukocytes isolated in DPBS with (n=5) or without (n=4) Ca2*, Mg2*. 
Error bars less than the symbol width are not shown.
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Freshly Isolated Compared to Cultured Leukocytes and Myometrium
The binding affinity (KD) and total receptor number ( B ^  for I2SI-iodopindolol at 
B-ARs were similar in fresh leukocytes and leukocytes cultured for three days (Table 1, 
paired t-test, n=4).
In both fresh and cultured leukocytes (Fig. 6) cAMP was significantly increased by 
isoproterenol (1 pM), forskolin (24 pM), and PGEt (10 pM), but not by A1F4* (10 mM 
NaF /10 pM A1C13). After culture for three days in medium containing 10% FCS, there 
was an 85% decrease in basal, isoproterenol, A1F4', and forskolin cAMP production, and a 
70% decrease in PGEj-stimulated cAMP production.
Table 1. l2SI-IODOPINDOLOL Kd AND IN LEUKOCYTES BEFORE 
AND AFTER CULTURE
Before Culture After Culture
Kd
(picoMolar)
33.1 ±5.2 34.6 ±8.9
BmaX
(Sites per Cell)
525 ± 79 796 ±217
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Figure 6. Basal and isoproterenol-, A1F4'-, forskolin-, PGEj-stimulated 
cAMP production were compared between freshly isolated (n=9) and three 
days cultured (n=9) leukocytes. represents a significant difference from 
group basal.
Total B- and B2-AR number in myometrium membranes decreased significantly 
during the disaggregation and first 24 hours in culture (Fig. 7; Table 2). The B,-AR density 
and percentage did not change significantly in cells cultured for 24 hours. Nonspecific 
binding was 61.8 ± 1.7% of total binding at 35 pM 125I-iodopindoIol.
Forskolin-stimulated cAMP production was significantly increased in fresh 
myometrium but not in disaggregated myometrium or myometrial cells cultured for 24 
hours (Fig. 8). There was no difference between basal and isoproterenol-stimulated cAMP 
levels in either fresh, disaggregated, or 24 hour cultured myometrium.
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Figure 7. The density of total B-ARs, B2-ARs, and B,-ARs in membranes 
prepared from fresh human myometrium, disaggregated cells, and cells 
cultured for 24 hrs. “+” represents a significant difference from fresh 
myometrium by ANOVA and Dunnet’s multiple comparison, n=8 .
Table 2. TOTAL, Br , AND B2-AR DENSITY IN FRESH HUMAN MYOMETRIUM, 
DISAGGREGATED MYOMETRIUM, AND 24 HOURS CULTURED 
MYOMETRIUM (Data for Fig. 7).
Unit:
(finol/mg protein)
Fresh Myometrium Disaggregated
Myometrium
Cultured
Myometrium
Total B-AR 4.76 ± 0.22 3.48 ± 0.19+ 2.67 ± 0.30+
b2-a r 3.93 ± 0.29 2.89±0.16+ 2.10 ± 0.24+
Br AR 0.83 ±0.18 0.58 ±0.10 0.58 ±0.14
“+” represents a significant difference from the fresh myometrium.
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Figure 8. Basal, isoproterenol- and forskolin-stimulated cAMP production in 
membranes prepared from fresh human myometrium, disaggregated cells, and 
cells cultured for 24 hrs. represents a significant differences from group 
basal. “+” represents a significant differences from fresh myometrium by 
ANOVA and Dunnet’s multiple comparison, n=8 .
Human Mvometrial Smooth Muscle Culture and Identification
Mvometrial Cell Culture
Cultured myometrial cells were confluent (Fig. 9) after one to two weeks of 
incubation depending on the number of cells placed in the flask, and were used within 
seven passages.
Mvometrial Smooth Muscle Cell Identification
The spindle-shaped fluorescence pattern following treatment with phalloidin 
CPITC was characteristic o f myometrial smooth muscle (Fig. 10). Myofibroblasts have a 
basket-weave fluorescent pattern following phalloidin treatment (Casey and others 1984).
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Figure 9. Confluent myometrial cells grown in DMEM-F12 medium containing 
10% FCS. Magnification = 128 fold.
Figure 10. Cultured myometrial cells stained with fluorescent phalloidin, a 
fluorescent toxin specific for filamentous actin. The spindle-shaped fluorescent 
pattern is characteristic of myometrial smooth muscle. Magnification = 200 
fold.
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Comparison o f fl-Adrenoceptors between Cultured Leukocytes and Mvometial Cells 
Total binding of l25I-iodopindolol to B-ARs was resolved in both leukocytes (Fig.
11) and myometrial cells (Fig. 12) by curve-fitting using a model of a specific and 
nonspecific binding.
6OOO1
Total Binding
4500-
3000- Nonspecific Binding
1500 Specific Binding
0 100 200 300 400 500 600
[125l-Pindoloq, pM
Figure 11. A representative saturation binding curve for l25I-iodopindolol in 
human mononuclear leukocytes. Total binding was mathematically separated into 
specific and nonspecific binding.
125I-iodopindolol binding was saturable and displayed properties of a single specific 
binding site in both leukocytes and myometrial cells. The binding affinity (KD) and 
receptor density (B,^*) were obtained from specific binding to B-ARs (Table 3, n=7). KD 
values were similar for leukocytes and myometrial cells (p>0.6). Receptor density (B ,^ )  
was 43% higher for myometrial cells compared to leukocytes (p=0.06). Nonspecific
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Figure 12. A representative saturation binding curve for 125I-iodopindolol in 
cultured human myometrial cells. Total binding was mathematically separated 
into specific and nonspecific binding.
binding was approximately 25% and 49% of total binding in leukocytes and myometrial 
cells respectively at KD concentration.
Table 3. BINDING CHARACTERISTICS FOR 125I-IODOPINDOLOL IN 
MONONUCLEAR LEUKOCYTES AND MYOMETRIAL CELLS
Kd ®MAX
picoMolar Sites per Cell
Leukocytes 34.3 ± 13.1 673 ± 64
Myometrial Cells 27.1 ± 4.7 962 ±  121
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Comparison of cAMP Production between Cultured Leukocytes and Mvometrial Cells 
The difference between basal and maximal isoproterenol-stimulated cAMP 
production was 66% in fresh leukocytes, 61% in three day cultured leukocytes, and 15% 
in myometrial cells (Fig. 13). There were no differences between EC^ values for 
isoproterenol in freshly isolated leukocytes (17.5nM; 95% confidence intervals of pECjo = 
8.04 to 7.47) and myometrial cells (39nM; 95% confidence intervals of pEC*, = 9.17 to 
5.65), or cultured leukocytes (164 nM; 95% confidence intervals of pEC^ = 7.39 to 6.18) 
and myometrial cells, but cultured leukocytes had a significantly higher ECso than freshly 
isolated leukocytes.
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Figure 13. Isoproterenol-stimulated cAMP production in freshly isolated 
leukocytes (n=9), three days cultured leukocytes (n=9), and cultured 
myometrial cells (n=12).
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cAMP production was also compared following stimulation using B-AR agonist 
isoproterenol, G protein activator A1F4', AC stimulator forskolin and PGE, in freshly 
isolated leukocytes, leukocytes cultured for three days, and untreated cultured myometrial 
cells (as shown in Fig. 14; Table 4). Myometrial cells had significantly higher basal cAMP 
production compared to freshly isolated leukocytes (16.5 ± 3.0 compared with 5.6 ± 0.8 
pmol/106 cells/15 min; p<0.01). Myometrial cell forskolin- and PGE^stimulated cAMP 
production (381 ± 72 and 430 ± 87 pmol/106 cells/15 min) was > 10-fold higher than that 
in freshly isolated leukocytes (23 ± 6 and 41 ± 3 pmol/106 cells/15 min), but was 
depressed in leukocytes maintained in culture for three days (4.1 ± 0.9 and 12.6 ±1.6 
pmol/106 cells/15 min). When using data in Fig. 13, basal cAMP production expressed as a 
percentage of isoproterenol maximum was significantly greater (p<0 .0001) for myometrial 
cells (64 ± 7%) than for fresh (24 ± 3%) or cultured leukocytes or (28 ± 5%). For each 
tissue, cAMP production increased significantly following stimulation with isoproterenol, 
forskolin or PGEL Stimulation of G-proteins by A1F4* increased cAMP production in 
leukocytes by 16% (p=0.26), but decreased cAMP production in myometrial cells by 27%
(p=0 .10).
Comparison of B-Adrenoceptor Subtvpes between Cultured Leukocytes and Mvometrial
Cells
B2-selective antagonist ICI-118551 displaced t25I-iodopindolol binding in cultured 
leukocytes (Fig. 15) with two distinctive dissociation constants for B, (logK ^ -6.7 ±
0.21) and B2 (logK ^ -10.0 ± 0.65) adrenoceptors. The ratio of Bi : B2 was 3 : 1 in
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Figure 14. cAMP production stimulated by isoproterenol, A1F4\  forskolin, 
and PGE, was compared in freshly isolated, three days cultured leukocytes, 
and cultured myometrial cells. represents a significant difference from 
group basal (n=9) by paired t-test.
Table 4. BASAL, ISOPROTERENOL, A1F4\  FORSKOLIN, AND PGE, STIMULATED 
cAMP PRODUCTION IN FRESH LEUKOCYTES, THREE DAYS CULTURED 
LEUKOCYTES, AND CULTURED MYOMETRIAL CELLS (Data for Fig. 14)
Unit: pmol/106 
cells/15 min
Fresh Leukocytes Cultured
Leukocytes
Cultured
Myometrium
Basal 5.59 ±0.79 0.88 ±0.16 16.5 ±3.0
Isoproterenol 23.6 ±2.7* 3.59 ±0.55 * 26.7 ±4.8*
aif4- 6.47 ± 0.65 0.82 ± 0.11 12.0 ± 1.9
Forskolin 23.2 ±6.2* 4.10 ±0.88 * 381 ± 7 2*
PGEX 41.4 ±3.4* 12.6 ± 1.6 * 430 ± 87 *
“*” represents a significant difference from group basal.
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Figure 15. Displacement of I23I-iodopindolol binding by ICI-118551 in 
cultured human mononuclear leukocytes (n=6).
leukocytes. A two site model fit significantly better than a one-site model (FU6 = 11.49, P 
<0 .01).
ICI-118551 displaced l25I-iodopindolol from myometrial cells (Fig. 16) 
characteristics of a single 3, site with a logK*, of -6.4 ± 0.07. A two site binding model 
did not fit the data significantly better than a one-site model (F^10 = 1.627, p = 0.244). 
There was no significant difference between the IC*, values for Bj-ARs of leukocytes and 
myometrial cells.
To determine if displacement binding in whole cells provided an accurate estimate 
of B-AR subtypes, experiments were performed in fresh leukocytes, an established B2 
model (Brodde and others 1981). In intact fresh leukocytes (Fig. 17), a two site model 
fitted significantly better than a one site model (Fil5 =10.12, P< 0.01). Two distinctive
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constants were logKil = -5.7 ± 0.19 for Bt and logK^ = - 11.1 ± 0.98 for B2. The ratio of B,
: B2 was 4:1.
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Figure 16. Displacement of l25I-iodopindolol binding by ICI-118551 in 
cultured human myometrial cells (n=4).
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Figure 17. Displacement of 125I-iodopindolol binding by ICI-118551 in fresh 
human mononuclear leukocytes (n=9).
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B-Adrenoceptor Agonists Potencies between Cultured Leukocytes and Mvometrial Cells 
B-AR agonists differ in both EC*, and maximum effect in fresh leukocytes (Fig.
18). Isoproterenol was the most potent (EC^ =15.5 nM) and produced maximal cAMP 
production at concentrations above 1 pM. Terbutaline was less potent (EC^ = 373 nM) 
than isoproterenol but produced similar cAMP production at 10 pM. Ritodrine was 
considerably less potent and produced a significant increase in cAMP production only at 
the highest concentration tested (1 mM).
In cultured myometrial cells, isoproterenol differed from basal only when larger 
numbers of patients are included (compare Fig. 14 & Fig. 19). Terbutaline and ritodrine 
produced no change in cAMP production in cultured myometrial cells (Fig. 19).
Effect of Long-term 200 nM Terbutaline Exposure
B- Adrenoceptors
B-Adrenoceptor number decreased in both leukocytes and myometrial cells after 
exposure to 200 nM terbutaline. Leukocyte B-AR number decreased 20% when incubated 
for one day and was significantly reduced by 27% when incubated for three days (Fig. 20). 
Myometrial B-AR number significantly decreased by 42% when incubated for one day and 
by 28% after three days. There were no changes noted in the dissociation constant (KD) of 
ICI-118551 in either leukocytes or myometrial cells during the three days exposure to 200 
nM terbutaline.
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Figure 18. cAMP production in response to B-agonists isoproterenol, 
terbutaline, and ritodrine in freshly isolated leukocytes (n=5).
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Figure 19. cAMP production in response to B-agonists isoproterenol, 
terbutaline, and ritodrine in cultured myometrial cells (n=4).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
1250*1 ■  Leukocytes
0
IL.
*
Control 1 DAY 3 DAY
Figure 20. Total B-adrenoceptor number (Bmax) changes after 200nM 
terbutaline treatment for one or three days in cultured leukocytes (n=4) and 
myometrial cells (n=4). represents a significant difference from control by 
paired t-test.
cAMP Production
Basal, isoproterenol-, A1F4*-, forskolin-, and PGEr stimulated cAMP production 
were significantly higher in myometrial cells than in cultured leukocytes. Leukocytes 
exhibit a significant decrease in isoproterenol-coupled cAMP production following one 
day or three days exposure to terbutaline (Fig. 21; Table 5). Myometrial cells also have a 
significant decrease in isoproterenol-coupled cAMP production (compared by paired t- 
test) following three days of terbutaline treatment (Fig. 22; Table 6). There was no 
significant change in A1F4', forskolin, or PGE, stimulated cAMP production following one 
or three days exposure to 200 nM terbutaline. The percentage of forskolin- to PGEr  
stimulated cAMP production in the control group is 21% in leukocytes and 88% in 
myometrial cells. The ratio of isoproterenol- to forskolin-stimulated cAMP production in 
the control group is 1.36 in leukocytes and 0.036 in myometrial cells.
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Figure 21. cAMP production under basal condition and after A1F4*, forskolin, 
and PGE, stimulation was not changed following one or three days exposure 
to 200nM terbutaline, except that isoproterenol-coupled cAMP production 
significantly decreased after one and three days treatment in human 
mononuclear leukocytes (n=3). represents a significant difference from 
control by ANOVA and Dunnet’s multiple comparison.
Table 5. cAMP PRODUCTION BEFORE AND AFTER STIMULATION WITH 
ISOPROTERENOL, A1F4\  FORSKOLIN, AND PGE, IN LEUKOCYTES EXPOSED 
TO 200 nM TERBUTALINE FOR 0 (CONTROL), 1, OR 3 DAYS (Data for Fig. 21)
Unit: pmol/106 
cells/15 min
Control 1 Day 3 Day
Basal 0.71±0.15 0.63±0.12 0.68±0.18
Isoproterenol 5.00±1.22 1.56±0.85* 1.05±0.19*+
a if4- 1.01±0.34 0.75±0.15 0.96±0.14
Forskolin 3.68±0.2r 3.44±0.20+ 3.00±0.27+
PGE, 17.82±1.75* 16.70±2.52+ 14.93±2.10+
“+” represents a significant difference from the basal of that same day. 
represents a significant difference from control stimulation group.
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Figure 22. cAMP production under basal conditions and after A1F4‘, 
forskolin, and PGE, stimulation was not changed following one or three day 
exposure to 200nM terbutaline, except that isoproterenol-coupled cAMP 
production significantly decreased after three days treatment in cultured 
human myometrial cells (n=4). represents a significant difference from 
control by pair t-test.
Table 6. cAMP PRODUCTION BEFORE AND AFTER STIMULATION WITH 
ISOPROTERENOL, A1F/, FORSKOLIN, AND PGE, IN MYOMETRIAL CELLS 
EXPOSED TO 200 nM TERBUTALINE FOR 0 (CONTROL), 1, OR 3 DAYS (Data for 
Fig. 22)
Unit: pmol/106 
cells/15 min
Control 1 Day 3 Day
Basal 9.22±3.34 9.65±3.26 9.50±3.11
Isoproterenol 12.51±4.05+ 9.72±2.93 10.32±3.76*
aif4- 12.11±1.17 11.71±0.31 9.14±2.54
Forskolin 348.4±59.8 409.3±74.5 405.4±5.8+
PGE, 394.2±93.0 480.9±60.9 629±229
“+” represents a significant difference from the basal of that same day. 
represents a significant difference from control stimulation group.
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O-Adrenoceptor Subtypes in Isoproterenol-Induced Mvometrial Relaxation 
Potassium chloride (35 mM) produces a phasic contraction of human myometrial 
strips followed by a less intense tonic contraction. When this tonic contraction was 
designated as 100% after ten minutes of exposure and compared to resting tension (0%), 
only an 8% further relaxation occurred over the following 45 minutes (Fig. 23). In the 
presence of isoproterenol a concentration-dependent decrease in contraction occurred to 
26 ± 5% at 1 pM.
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Figure 23. Isoproterenol relaxation of myometrium contracted with 35 mM 
KCI (n=5).
Isoproterenol produced a maximum relaxation of 46.5% (from 4.1 ± 1.3% at 10'9 
M to 50.6 ± 3.6% at 10'5 M) with a pEC^ of 7.39 ± 0.05 (Fig. 24). In the presence of 0t- 
antagonist CGP-20712A, isoproterenol-induced myometrial relaxation was similar to 
control with a maximum relaxation of 41.6% (from 1.2 ± 0.6% at 10'9M to 42.8 ± 5.6%
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at 10*s M) and pECM of 7.31 ± 0.12. In the presence of B2-antagonist ICI-118551, 
isoproterenol-induced myometrial relaxation was shifted to the right and depressed, with a 
maximum relaxation of 23.5% (1.5 ± 0.6% at 10'9M to 25.0 ± 5.6% at 10'5 M) and a 
pEC^ of 5.97 ± 0.10 (n=8). In control and CGP-20712A treated tissues, isoproterenol 
produced contraction at concentrations above 10 pM. When determined from 
concentration-effect curve shifts at ECIS, the pKB o f ICI-118551 is9.11 ±0.21.
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Figure 24. Isoproterenol-induced myometrial relaxation in the absence 
(control) and presence of ICI-118551 or CGP-20712A (n=8).
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CHAPTER 4
DISCUSSION
The current experiments were designed to compare leukocyte and cultured 
myometrial cells in terms of B-adrenoceptors, cAMP production and response to 
terbutaline exposure. The goal of these experiments was to understand more about the 
relationship between pregnant human myometrium, fresh and cultured leukocytes, and 
cultured myometrial cells.
Establishment of Experimental Conditions
Leukocyte Cell Culture
In the present study, leukocytes from male volunteers were used to minimize the 
impact of patient hormonal status on B-ARs and cAMP coupling. Even though menstrual 
changes produce no effect on B-ARs in women (Santala and others 1990), menstrual 
effects on cAMP production have not been established. Although uterine samples obtained 
during Cesarean delivery may vary in hormonal status, by the time these smooth muscle 
cells are grown in culture for 10 to 14 weeks and used experimentally their hormonal 
status should be dictated by the growth medium.
Leukocytes were isolated in the presence o f calcium and magnesium since 
omission of these ions at any time during the isolation procedure resulted in a dramatic 
decrease in cAMP production. Phosphodiesterase inhibitor IBMX was added at
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concentrations that maximized stimulated cAMP production with minimal effects on basal 
cAMP production.
Mvometrial Cell Culture
Conditions for cultured human myometrial smooth muscle cells were similar to 
those reported by other investigators (Casey and others 1984). FCS 10%, different 
collagenases in a variety of cell culture media, including MEM, DMEM, or DMEM/Ham's 
FI 2 , and with varying concentrations of antibiotics have been used successfully during 
tissue dispersion or culture (Zhu and others 1992; Erulkar and others 1993; Komyei and 
others 1993). Human myometrial smooth muscle cells have a doubling time of 41.6 hours 
(Rossi and others 1992), and can be cultured for at least 16 passages or for one year 
without loss of smooth muscle characteristics (Casey and others 1984).
Cultured human myometrial smooth muscle cells were identified by Casey and 
others (1984) using phallacidin, a filamentous actin-binding fluorescent compound derived 
from Amanita phalloides. This is similar to the phalloidin coumarin phenyl isothiocyanate 
(phalloidin-CPITC) used in current study for morphologic evaluation o f myometrial 
smooth muscle cells. Casey and others (1984) found long, parallel arrays of filamentous 
actin to be characteristic of smooth muscle cells in situ, whereas a net-like pattern of 
staining is characteristic of fibroblasts. The intensity of fluorescence observed in smooth 
muscle cells was much greater than in myometrial fibroblasts, suggesting that filamentous 
actin was more abundant in smooth muscle cells. Other groups have instead used 
immunofluorescence microscopy with antibodies against smooth muscle specific a-actin,
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desmin, and/or vimentin (Rossi and others 1992; Erulkar and others 1993; Korayei and 
others 1993). With these methods, they determined that more than 90% of cultured cells 
were smooth muscle cells. Fluorescence microscopy of cultured myometrium in the 
current study suggests an almost pure population of myometrial cells (Fig. 9).
Cultured myometrial cells have been shown to reflect myometrium muscle in 
biochemical and electrophysiological studies. Myometrial muscle strips and cultured 
myometrial cells have similar myosin content, myosin light chain kinase activity, and 
increase in intracellular calcium concentration following KCI stimulation (Richardson and 
others 1987). Platelet-activating factor receptors with properties similar to those of human 
myometrium are found in cultured human myometrium and produce an increase in 
intracellular Ca2+ concentration and myosin light chain phosphorylation in the presence of 
platelet-activating factors (Zhu and others 1992). Potassium channels exist in both 
cultured human myometrium (Erulkar and others 1993) and myometrium muscle strips 
(Wallner and others 1995). Cultured myometrium contains human chorionic gonadotropin 
hCG/LH receptors, which increase the growth rate (Komyei and others 1993) and are also 
found in myometrium (Eta and others 1994). Endothelin receptor and myosin light chain 
phosphorylation have been demonstrated in tissue and cultured cells (Word and others 
1990, 1991). The present study measured B-AR density, receptor coupled cAMP 
production and down-regulation following prolonged terbutaline exposure in intact 
cultured human myometrial cells. These experiments further evaluate the culture model in 
terms of B-ARs.
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Saturation Binding Conditions
Saturation binding studies were designed to measure the total B-ARs in intact cells. 
Radioligand t25I-iodopindolol was chosen because of its high affinity for the B-AR and low 
nonspecific binding. Its lipophilicity permits the ligand to pass through the cell membrane 
and bind to both membrane and internalized B-ARs. Moreover, 125I-iodopindolol binding in 
cell membranes is inhibited by isoproterenol and retains stereoselectivity for inhibition by 
(-)- and (+)-propranolol (Szefler and others 1987).
Isolated intact cells were chosen because of the advantage of maintaining a 
structural and metabolic state close to that which exists in vivo (Williams and Lefkowitz 
1978), and estimating total B-ARs without a loss of receptors during membrane 
preparation (Santala and others 1989). Studies using intact cells can be performed using 
less tissue than studies requiring isolation of membrane protein, but intact cells are subject 
to clumping, and can also take up ligand into intracellular compartments more readily than 
membrane preparations (Marinetti and others 1983).
Although the incubation temperature was chosen according to physiological body 
temperature, incubation temperature does not affect saturation binding of I25I-iodopindolol 
in intact human lymphocytes (Waldo and others 1983; Thede-Reynolds and others 1986).
Displacement Binding Study
ICI-118551, a more selective B2-AR antagonist than butoxamine or atenolol in 
displacing 12sI-iodopindolol, was chosen because its dissociation constants for B2- and B,- 
ARs are distinctly different. The dissociation constants for B2- and Br ARs are 0.1 nM and
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0.2 pM respectively in intact cultured leukocytes. These values are similar to those 
reported by Molenaar and Summers (1987) and Molenaar and others (1988) in both 
guinea pig atrium and canine coronary artery (KD values around I nM for B2-ARs and 0.13 
pM for B,-ARs). The KD values for Br AR antagonist CGP-20712A are 1 nM for B,-ARs 
and 10 pM for B2-ARs (Molenaar and Summers 1987; Molenaar and others 1988). These 
data suggest both compounds are highly selective and might be useful in differentiation of 
B-AR subtypes.
Using displacement binding in intact fresh leukocytes showed 80% Br ARs.
%
Brodde and others (1981) used membrane preparations of human lymphocyte and found 
100% B2-AR subtype. This difference may be due to the inability of ICI-118,551 to 
penetrate through the intact cell membrane and displace iodopindolol binding. Therefore, 
membrane preparations provide a better estimation of B-AR subtypes than intact cells. The 
evaluation of Br AR predominant in intact cultured leukocytes and myometrial cells 
appears to be artificial and displacement binding in membrane preparations should be 
considered.
Displacement binding in the membrane preparation of myometrium from tissue, 
disaggregated cells and culture cells measured the total B-AR, B-AR subtypes and 
presented results in the same units (fmol/10  min/mg protein).
Comparison of Cultured Leukocytes and Mvometrial Cells 
B-Adrenoceptors
The leukocyte B-AR binding affinity (KD) for 125I-iodopindolol of 34.3 ±13.1 pM
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(Table 2) is within the range reported by other studies (Marsh and Smith 1985; Thede- 
Reynolds and others 1986; Kowalski and others 1990; Landmann, 1992; Nwosu and Rice 
1995). In the current study, the B-adrenoceptor of 673 ± 64 sites per cell is similar to 
that reported by O'Hara and Brodde (1984), Thede-Reynolds and others (1986), and 
Nwosu and Rice (1995), but relatively lower than the range of 1000-3000 sites per cell 
reported by Landmann (1992). The B-AR density for human leukocyte subpopulation 
estimated by antagonist radioligand iodocyanopindolol can vary from 3746 sites per B cell 
to 642 sites per T cell (Landmann 1992). The presence o f leukocyte subpopulations 
containing different B-AR density can explain interpatient variation in B ^ ^  and cAMP 
production. Landmann (1992) also found that isoproterenol infusion or short periods of 
exercise lead to an increased number of mononuclear B-ARs having a slightly reduced 
proportion with high agonist affinity. This raises the issue of whether leukocytes can be an 
precise index o f myometrium, a tissue containing a homogeneous receptor population at 
term (Breuiller and others 1987).
Myometrial ,25I-iodopindolol binding affinity (KD; 27.1 dh 4.7 pM) was similar to 
that reported by Michel and others (1989) (40.0 ± 4.2 pM) in a human myometrial 
membrane preparation, and in intact leukocytes (Table 2). Our total B-AR number in 
myometrial membranes (4.76 ± 0.22 fmol/mg protein at Fig. 7) is similar to that in the 
human myometrium at term (5 fmol/mg protein) reported by Breuiller and others (1987). 
Our B-AR number is lower than that reported by Michel and others (1989); (16.4 fmol/mg 
protein) this may be due to differences in gestational age or sample location which were 
not described in their paper.
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cAMP Production
Myometrial cells have higher basal cAMP production than either freshly isolated or 
cultured leukocytes, and can be significantly stimulated by isoproterenol at 1 pM 
concentration (Fig. 13, 14). The percentage increase of isoproterenol-stimulated cAMP 
production is lower (15%) than in leukocytes (60%). In myometrial membranes from fresh 
tissue, disaggregated tissue, and cells cultured for 24 hours (Fig. 8), isoproterenol- 
stimulated cAMP production is not significantly different from basal. Litime and others 
(1989), Grammatopoulos and others (1996), and Breuiller and others (1991) also reported 
disappearance of B-adrenergic response in human myometrial adenylyl cyclase in vivo at 
the end o f pregnancy. Reasons for this phenomenon are poorly understood, but may 
include a higher basal level of cAMP production. Litime and others (1989) found a 
decrease in the number of B-ARs in the last weeks of pregnancy, with an increase in basal 
cAMP production, a loss of B-AR mediated cAMP production and reduced G-protein 
coupling to adenylyl cyclase without a change in direct adenylyl cyclase stimulation. They 
implicated modifications in the coupling mechanisms between receptors and the catalytic 
component of adenylyl cyclase. Some researchers have suggested that involvement of G 
protein might be a further investigative direction in explaining this phenomenon. Europe- 
Finner and others (1993) used antibodies against Gia„ Gia^ Gia3, Gqa, and Gsa, to 
compare changes in G proteins between pregnant and nonpregnant human myometrial 
tissues and reported that increased Gsa levels play a crucial role in maintaining uterine 
relaxation by favoring cAMP formation during pregnancy. Down-regulation of Gsa
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occurs in human myometrium at term and in preterm labor (Europe-Finner and others 
1994).
The present data comparing the Gs protein stimulation between cultured 
leukocytes and myometrial cells failed to provide any significant evidence. Two 
explanations are considered for the inability of AJF4* to significantly affect cAMP 
production in either leukocytes or myometrium. A1F4* may not pass through the intact cell 
membrane and so fail to stimulate the G protein coupled cAMP level for either leukocytes 
or myometrial cells. Second, A1F4* may partially enter the cells, and activate both Gs and 
Gi proteins (Coggeshall and Altman 1989), producing an insignificant decrease in 
myometrial cells, and an insignificant increase in leukocytes (Fig. 14). This explanation 
would imply that the balance between stimulatory Gs protein and inhibitory Gi protein are 
different in leukocytes and myometrial cells. The Gi protein may predominate in 
myometrial cells while Gs predominates in leukocytes.
B-AR agonist isoproterenol has a higher potency in leukocytes than the B2-AR 
agonists terbutaline and ritodrine (Fig. 18). These results indicate that isolated leukocytes 
are a potential model for comparing the cAMP coupling potencies of B-AR agonists. In 
contrast, isoproterenol, terbutaline and ritodrine have no effect on cultured myometrial 
cells (Fig. 19). The 1 pM isoproterenol stimulated cAMP production was only significant 
when large numbers of tissues were studied (Fig. 14, n=9). This difference between 
leukocytes and myometrial cells implies a different activity of B-AR coupling to adenylyl 
cyclase.
The basal cAMP level in leukocytes and myometrium may be regulated differently.
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In leukocytes, both basal cAMP level and forskolin stimulated adenylyl cyclase activity 
decrease after three days of culture (Fig. 6). In myometrium, forskolin stimulation of 
myometrial adenylyl cyclase activity decreases during the time from tissue isolation to 24 
hours culture (from 167.6 to 46.8 pmol/10  min/mg protein) (Fig. 8). However, basal 
cAMP level did not change during myometrial cell isolation. Although the factors 
regulating myometrial basal cAMP level at the end of pregnancy are unknown, the basal 
cAMP level in the present study is not affected by B-AR number or total adenylyl cyclase 
activity measured by forskolin.
Long-term Terbutaline Exposure
B-AR density and isoproterenol-stimulated cAMP production were decreased in 
both leukocytes and myometrium after continuous treatment with B2-AR agonist 
hexoprenaline (Michel and others 1989) or terbutaline (Berg and others 1984, 1985). The 
routes of administration and dosages of terbutaline used by Berg and others (1984) make 
it difficult to compare plasma concentration with the current study. Terbutaline plasma 
concentrations which inhibit uterine contraction range from 57 to 140 nM (Lyrenas and 
others 1986). The terbutaline concentration of 200 nM used in current study, should be 
typical of concentrations achieved clinically and is sufficient to induce a decrease in B-AR 
density (Fig. 20) and isoproterenol-stimulated cAMP production in both cultured 
leukocytes (Fig. 21) and myometrial cells (Fig. 22).
Agonist-induced homologous desensitization is a complex process. It involves the 
uncoupling of the receptor from Gs protein through the phosphorylation by B-AR kinase
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(Benovic and others 1988), and receptor internalization and sequestration as well as later 
degradation (down-regulation) o f the receptor (Benovic and others 1988). Although 
agonist-induced down-regulation of B-ARs has been well documented (Stiles and others 
1984; Hausdorff and others 1990; Dohlman 1991; Von Zastrow and Kobilka 1992), 
investigations dealing with the agonist-induced changes in G proteins, AC, and the PGE1 
heterologous pathway are unreported. To elucidate which components are altered during 
down-regulation, cAMP production stimulated by isoproterenol, G protein activator A1F4‘, 
AC stimulator forskolin, and PGE, were measured following terbutaline-induced B-AR 
down-regulation in leukocytes and cultured myometrial cells. Data in this study 
demonstrate that the activity.of AC and the PGE! pathway has not changed during 
terbutaline-induced B-AR down-regulation (Figs. 21, 22). This characterization of 
desensitization to B-AR agonists is similar to the findings by Dayes and Lye (1990), and 
Engelhardt and others (1997). Dayes and Lye (1990) found continuous exposure of ovine 
myometrial strips to isoproterenol (10 pM) induces a state of desensitization that is 
associated with a down-regulation of B-ARs but maintenance of postreceptor function. 
Engelhardt and others (1997) found long-term use of B-AR agonist fenoterol causes a 
decrease in B-AR but not in mRNA, Gs, Gi, or B-AR kinase activity.
The high PGE^stimulated AC activity in both leukocytes and myometrial cells 
suggests that both cell types have reserve AC activity not used by B-ARs. The ratio of 
cAMP production following forskolin to that following PGE, is higher in myometrial cells 
than in leukocytes suggesting that myometrial cell AC has a higher sensitivity to forskolin 
than leukocytes, and that the AC isozyme in myometrial cells may be different from that in
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leukocytes. The ratio of cAMP production following isoproterenol and forskolin is higher 
in leukocytes than in myometrial cells. This result further supports that the efficacy of 
isoproterenol-stimulated cAMP production in leukocytes is higher than that in myometrial 
cells.
Fresh Tissue Versus Cultured Cells
Myometrium Functional Studies
KC1 produces phasic contractions at low concentration, but tonic contraction at 
higher concentration. Phillippe and Chien (1995) found KC1 at 10 to 30 mM can stimulate 
phasic myometrial contraction by utilizing cytosolic calcium oscillation-like mechanisms. 
These potassium-stimulated phasic contractions were suppressed in response to inhibition 
of phospholipase C, stimulation of protein kinase C, inhibition of calcium-induced calcium 
release, and prevention of extracellular calcium influx. Qualitative inositol-phosphate 
production studies confirmed activation of phospholipase C in response to 20 mM 
potassium (Phillippe and Chien 1995). Rat myometrium cell shortening and tonic 
contraction of muscle strips occurred while depolarizing with 60 mM KC1 in 2 mM Ca2+ 
solution; no contractions occurred if nitrendipine or 4 mM of EGTA was added (Kyozuka 
and others 1987). This result suggests that Ca2+ influx is necessary to maintain tonic 
contraction following high K* depolarization (Fig. 1).
Although Bj-ARs are predominant and known to produce uterine relaxation, the 
role of cAMP coupling and B,-ARs in uterine relaxation has not been explored. In the 
present study, the nonselective B-AR agonist isoproterenol was used to relax human
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myometrium. According to Arunlakshana and Shild (1959) analysis in detection of 
heterogeneous receptor population, the assumption of linearity and slope of unity between 
logarithmic antagonist concentrations and log dose ratio can be used to estimate the 
antagonist dissociation constant. Nonlinearity and a slope of less than unity may be 
obtained for Schild regressions at dose ratios less than 10. Therefore, two competitive B- 
AR antagonists, a Br AR antagonist (CGP-20712A, KD 10'9 M) and a B2-AR antagonist 
(ICI-118551, Kd 10'9 M), were used at concentrations 100-fold higher than their 
dissociation constants to differentiate the contribution of each receptor subtype (Molenaar 
and Summers 1987, Molenaar and others 1988). If 6,-ARs are mainly involved in uterine 
relaxation, the isoproterenol-induced relaxation dose response curve in the presence of 
CGP-20712A would exhibit a 100-fold parallel right shift from the control curve. If B,- 
ARs are mainly involved in uterine relaxation, the isoproterenol-induced relaxation dose 
response curve in the presence of ICI-118551 would exhibit a 100-fold parallel right shift 
from the control curve. A shift in the isoproterenol concentration-relaxation curve 
occurred in the presence of ICI-118551. Because isoproterenol contracted myometrium at 
concentrations above 1 pM, the shift in the concentration-effect curve was estimated at 
the ECIS. The pKB value o f 9.11 ± 0.21 for ICI-118551 is similar to that reported by Bilski 
and others (1980) and O’Donnell and Wanstall (1980) for antagonism at Bi- 
adrenoceptors, and suggests that B2-ARs mediate uterine relaxation at the end of 
pregnancy. Breuiller and others (1991) reported that isoproterenol cannot relax KC1- 
induced contractions in term human myometrium. Isoproterenol produced relaxation in all 
but one patient (out of 9) in the current study.
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Isoproterenol did not produce maximum relaxation in the presence of ICI-118551. 
The control and CGP-20712A pre-incubated groups demonstrated a contraction to 
isoproterenol concentrations above 10 pM. The fact that contraction occurred at high 
concentration o f isoproterenol alone, and in the presence of 8t- antagonist suggests at high 
concentration o f isoproterenol may interact with other adrenergic receptor subtypes. The 
a-AR is the most speculative one because of its link to uterine contraction and structural 
similarity to B-ARs. Although this phenomenon has not been reported in human 
myometrium, Kamata and others (1989) found that muscle contraction observed at high 
concentrations of isoproterenol can be blocked by non-selective a-antagonist 
phentolamine in rat aorta.
B-Adrenoceptors and cAMP
The fraction of B2-ARs in human myometrium membrane preparation (82.6%)
(Fig. 7) is similar to 85.1% reported by Michel and others (1989), but higher than the 63% 
B2-AR reported by Breuiller and others (1987). This difference may be within the variation 
of displacement binding studies.
Experiments with fresh myometrium were performed to examine B-AR, receptor 
subtypes and B-AR coupled cAMP production in parallel. The high percentage (82.6%) of 
B2-AR in the myometrium membrane displacement binding study indicates B2-ARs 
predominate in fresh human myometrium and also mediate relaxation by isoproterenol. 
cAMP production was not changed in the presence of isoproterenol (1 pM) which 
produced maximum relaxation. This result confirms the loss of B-AR coupling to cAMP
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production at the end of pregnancy as found by Litime and others (1989), Breuiller and 
others (1991), and Grammatopoulos and others (1996). It also supports the hypothesis 
that cAMP level does not reflect myometrial relaxation. The relationship between cAMP 
and uterine relaxation was evaluated by Do Khac and others (1986), who found 13- 
adrenoceptor mediated relaxation of the rat myometrium could not be ascribed solely to 
cAMP because PGEj also stimulates cAMP production but causes contraction. Therefore, 
they proposed that B-AR-linked relaxation includes a cAMP-dependent (sensitive to low 
cAMP) and a cAMP-independent process. The cAMP-independent process is postulated 
to produce a reduction in cytosolic Ca2+. cAMP would be the sole determinant for 
forskolin-elicited relaxation provided cAMP reached a critical concentration essential to 
mediate intracellular Ca2+ sequestration.
Isoproterenol was unable to stimulate adenylyl cyclase in fresh myometrial tissue 
which contained higher adenylyl cyclase activity and more B-ARs than disaggregated or 24 
hour cultured cells, suggesting that cAMP production is not determined by the number of 
B-ARs in this tissue (Fig. 7, 8). The positive correlation in the number of B-ARs between 
leukocytes and myometrium by Berg and others (1984), and Michel and others (1989) 
does not necessarily mean that B-AR stimulation triggers the same amount of cAMP 
production. Nwosu and Rice (1995) also found that cAMP production per receptor site is 
constant at higher receptor densities, but appears to be increased when receptor densities 
iire less than 400 sites per cell in human mononuclear leukocytes.
Since cAMP is not a good index for the relaxation of myometrium, and the 
existence o f B-AR does not assure stimulation of cAMP production, using leukocyte B-AR
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coupling to cAMP production as an index for myometrium relaxation requires further 
consideration. Additionally, leukocytes may be affected by patient’s emotion, hormonal 
status, immunological situation (infection etc.) and other indirect effects. Avissar and 
others (1997) found reduced G protein function and immunoreactivity in mononuclear 
leukocytes from patients with depression. Connolly and others (1992) found that there is 
an intrinsic impairment in the function of B-ARs on peripheral mononuclear leukocytes 
from subjects with high levels of nonspecific bronchial responsiveness. Szefler and others 
(1991) observed that a significant change in B-AR density and leukocyte function occurs 
at night in patients with nocturnal asthma. Zoukos and others (1994) found that increased 
expression of high affinity IL-2 receptors and B-ARs on peripheral blood mononuclear 
cells is associated with clinical and magnetic resonance imaging activity in multiple 
sclerosis patients. Brodde and others (1986) compared B-ARs in human right atria to 
circulating lymphocytes and obtained a direct relationship between human myocardium 
and lymphocyte B-AR alterations. Taken together, using leukocytes as an index of 
myometrium response may result in a poor estimation of uterine relaxation following B- 
agonist therapy.
Fresh and cultured leukocytes have similar total B-AR number (Table 1), while 
there is a loss of myometrium B-adrenoceptors during preparation and the first 24 hrs of 
culture (Fig. 7). This variation in leukocyte B-ARs may be due to leukocytes redistributing 
to subsets containing different B-AR density. Myometrium exhibits homogeneous receptor 
density at term (Breuiller and others 1987) but may lose B-ARs during culture preparation. 
This phenomenon may be independent from the binding preparation (intact cell or
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membrane preparation) and the location of the receptor (cellular membrane receptor or 
intracellular receptor). A similar loss of intracellular estrogen receptor occurs at different 
times after the intact rabbit uterine myocytes are isolated (Sadovsky and others 1992). 
Myometrium B-AR number is decreased by the loss of B,-ARs during disaggregation and 
24 hour culture.
While leukocyte B-AR number has not changed after three days of incubation, 
isoproterenol-, A1F/-, forskolin- and PGEj-stimulated cAMP production are each 
significantly decreased. The similar percentage decrease in basal and stimulated cAMP 
production suggests that a later step of the cAMP production pathway is depressed. The 
nature of the intracellular change leading to the loss of cAMP production capability in 
cultured leukocytes was not established, but does not involve either thyroid hormone, 
insulin, human serum, or attachment of a subpopulation of leukocytes to the culture flask.
B-AR coupling to cAMP production does not change during cell isolation and 
culture. The inability of B-ARs to couple cAMP production is maintained from fresh 
myometrium to myometrial cells cultured for 24 hours. In leukocytes, isoproterenol- 
stimulated cAMP production decreased after three days of culture (Fig. 6). However, the 
same percentage stimulation from basal to maximum cAMP level was obtained in fresh 
and cultured leukocytes (Fig. 13). These results indicate that the efficacy of B-AR 
coupling to cAMP production has not changed during the isolation or culture process for 
either leukocytes or myometrial cells. Furthermore, the loss in B-AR coupled cAMP 
production o f cultured myometrial cells may provide a model in studying the cause of 
receptor coupling changes at the end of pregnancy.
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In summary, cultured leukocytes and myometrial cells contain similar amounts of 
B-ARs capable of stimulation by isoproterenol, with reserve adenylyl cyclase activity not 
stimulated by B-AR. Down-regulation occurs following three days exposure to 200 nM 
terbutaline and is independent from adenylyl cyclase and PGE,-stimulated cAMP 
production. Cultured myometrial cells have higher basal cAMP production than 
leukocytes, but cultured leukocytes have higher potency in receptor coupling to cAMP 
production. Cultured myometrial cells have a low level of coupling to cAMP production 
not present in fresh tissue. B-AR coupling to cAMP production is maintained in both 
cultured leukocytes and myometrial cells. Isoproterenol produces relaxation o f term 
human myometrium through B2-adrenoceptors. cAMP production is not determined by the 
number of B-ARs in myometrium, nor does it reflect myometrial relaxation. Fresh 
leukocytes have similar receptor density as cultured leukocytes, but cultured leukocytes 
contain less adenylyl cyclase activity.
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CHAPTER 5
SUMMARY AND CONCLUSIONS
1. Human mononuclear leukocytes require the presence of Ca2+ and Mg2* during 
isolation to maintain AC activity. Freshly isolated leukocytes have similar B-AR density as 
cultured leukocytes, but have higher basal and stimulated adenylyl cyclase activities.
2. Cultured myometrial cells contain a pure population of smooth muscle cells. During 
the isolation and culture of myometrial cells, B2-ARs, but not B,-ARs, are lost.
3. B-ARs in cultured human mononuclear leukocytes and myometrial cells have similar 
I25I-iodopindolol binding affinity and receptor density. Both tissues can be stimulated by 
isoproterenol, but contain additional adenylyl cyclase activity not stimulated by B-ARs. 
Basal cAMP production as a percentage of isoproterenol-stimulated cAMP production is 
maintained from fresh tissue to cultured cells.
4. Cultured human myometrial cells have higher basal AC activity than leukocytes. 
Leukocytes have higher isoproterenol-coupled cAMP production than myometrial cells.
5. The rank order of B-AR agonist potencies in fresh leukocytes is: isoproterenol > 
terbutaline > ritodrine. Myometrial cells could not be stimulated by terbutaline or 
ritodrine.
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6. Long-term 200 nM terbutaline exposure causes a decrease of both B-AR number and 
isoproterenol-stimulated cAMP production in cultured leukocytes and myometrial cells. 
Signal transduction factors, like AC and the PGEt pathway, are not affected by the down- 
regulation process.
7. Isoproterenol-induced myometrium relaxation at term occurs through B2-ARs and is 
cAMP independent.
8. Cultured leukocytes do not completely reflect the activity of B-AR coupled cAMP 
production in myometrial cultured cells. In myometrium tissue, the existence of B-AR does 
not guarantee a stimulation of cAMP production, and cAMP is not the only index for 
myometrial relaxation at the end of pregnancy. While leukocytes may accurately reflect 
changes in myometrial B-adrenoceptors, postreceptor differences suggest that they are not 
a reasonable indicator of myometrial relaxation in response to B-AR stimulation.
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